Aptinyx Raises $70 Million to Expand Clinical-stage Pipeline in Therapies for Neurologic Disorders
Fibromyalgia, News
Aptinyx has completed a $70 million series B financing round to fund the expansion of its clinical-stage pipeline of therapies targeting neurologic disorders, including fibromyalgia. The funds will support clinical ... Read more